Target intelligence / Profile preview

Heat shock protein 90 alpha family class A member 2 pseudogene (HSP90AA2P)

Target
HSP90AA2P
Molecular classification
Other (Pseudogene)
01

Overview

HSP90AA2P is a predicted heat shock protein 90 alpha family class A member 2 pseudogene. It shares sequence similarity with functional HSP90 proteins, which are highly conserved molecular chaperones involved in the folding, maturation, and degradation of cellular proteins. HSP90AA2P itself lacks protein-coding function and is not established as a direct participant in protein folding, signaling, or disease mechanisms. The functional variants of HSP90 are well-studied for their critical roles in cellular stress responses and have clinical significance in cancer therapy as therapeutic targets, but HSP90AA2P is not among the protein-coding, druggable HSP90 family members. If your interest is in pharmacological targets within the HSP90 family, you should look at protein-coding genes such as "Heat shock protein 90 alpha" (HSP90AA1) or "Heat shock protein 90 beta" (HSP90AB1).

Other names
HSP90AA2PHSP90AA2Heat shock protein HSP 90-alpha A2 pseudogeneHSP90ALPHAHeat shock 90 kDa protein 1 alpha-like 3HSPC2HSPCAHeat shock protein family C member 2
02

Mechanism of action

null for the pseudogene. For functional HSP90 proteins, mechanism of action typically involves inhibition of ATP binding to disrupt chaperone activity.

03

Biological functions

No confirmed biological function. May be transcribed, but not translated into functional protein. Functional HSP90 genes serve as molecular chaperones.
04

Disease associations

No direct disease association as a pseudogene. Functional HSP90 proteins are implicated in cancer and other diseases due to their chaperone and regulatory functions.
05

Safety considerations

null for the pseudogene. Safety concerns such as off-target effects and toxicity are relevant to inhibitors of functional HSP90 proteins.
06

Interacting drugs

null for the pseudogene. Drugs such as geldanamycin, herbimycin, radicicol, and others are known to inhibit functional HSP90 proteins, not the pseudogene.
07

Biomarkers

null (The pseudogene itself is not used as a biomarker.)

Beyond the preview

Go deeper on Heat shock protein 90 alpha family class A member 2 pseudogene (HSP90AA2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein 90 alpha family class A member 2 pseudogene (HSP90AA2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call